Saturday, July 11, 2026
DD India
July 9, 2026 3:55 PM
Novo Nordisk India on Thursday announced the launch of Awiqli (insulin icodec), which the company says is the world's first once-weekly basal insulin for adults with Type 1 or Type 2 diabetes. The treatment reduces the insulin regimen from one inject...
August 22, 2025 8:07 PM
India’s drug regulator has issued an alert regarding the theft of several batches of injectable medicines belonging to Novo Nordisk during transit. According to a notice issued by the Drugs Controller General of India (DCGI), Dr. Rajeev Raghuvansh...
February 19, 2025 4:48 PM
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can increase the risk of falls and decrease overall strength, which coul...
December 20, 2024 5:26 PM
Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped patients cut their weight by 22.7% in a late-stage trial, below the 25% it had expected, wiping as much as $125 billion off its market value. The lower-than-e...
December 2, 2024 4:35 PM
Four oral glucagon-like peptide-1 receptor (GLP-1R) drugs, currently under Phase III trials, are in the race for approval, according to a report. This follows the immense popularity of injectable GLP-1R drugs, such as Novo Nordisk’s Wegovy and Sax...
October 15, 2024 7:33 PM
Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the ...
September 11, 2024 4:40 PM
Novo Nordisk said on Wednesday that its highly anticipated experimental weight-loss pill amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects. The maker of blockbuster drugs Wegovy and Ozempic sai...
August 1, 2024 5:26 PM
Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure, the company said on Thursday as it continues to build a case for the medicati...
July 30, 2024 4:00 PM
Smokers with type 2 diabetes taking Novo Nordisk’s Ozempic had fewer tobacco-related medical encounters and fewer interventions to help them quit smoking than those who received other diabetes drugs, according to a study of electronic health record...
July 11, 2024 7:35 PM
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of th...
Copyright © 2026 DD India. All rights reserved
Last updated on: 11th July 2026
